Similar Posts

Farid Moussavi-Harami

CTMR Pilot Grant Recipient Dr. Farid Moussavi-Harami awarded NIH R01 Grant

Byctmr1

A huge congratulations to 2020 CTMR pilot grant recipient Farid Moussavi-Harami, MD, who recently received a Notice of Award for his first NIH R01 grant! An Assistant Professor with the UW Medicine’s Division of Cardiology, Dr. Moussavi Harami’s CTMR pilot grant study focused on the genetic mutations, such as dilated cardiomyopathy, impacted contractile force in…

Registration Open for ISHR-JMCC Webinars (4/26 & 4/28)

Byctmr1

Registration is now open for the International Society for Heart Research-Journal of Molecular and Cellular Cardiology Webinars coming up in April! Register now using the links below. Please note time zones when registering: webinar times vary to capture audiences in different regions. Can’t join the webinar but still want to watch? All presentations will be…

CTMR represents at the 50th European Muscle Conference Florence 2023

Bykd

Dr. Mike Regnier is an invited speaker at the 50th European Muscle Conference (EMC) coming up in September 2023. The EMC will be in held in Florence, Italy. Dr. Regnier will be the “DISEASE MODELS” session chair and his talk title will be: “Molecular mechanisms of contractile abnormalities for the MYH7 variant G256E”. Graduate student,…

Bykd

CTMR/BioCAT collaboration leads to new PNAS paper “Structural OFF/ON transitions of myosin in relaxed porcine myocardium predict calcium-activated force“ The UW Center for Translational Muscle Research (CTMR) working with the Regnier Lab and the BioCAT x-ray beamline at the Advanced Photon Source of Argonne National Lab, explore the potential of sarcomere-targeted small molecules as treatments…

Dr. Ru Gunawardane joins CTMR External Advisory Board

Dr. Ru Gunawardane joins CTMR External Advisory Board

Byctmr1

We are excited to announce that Ruwanthi (Ru) Gunawardane, Ph.D. is joining CTMR as a member of our External Advisory Board. Ru was recently named Executive Director of the Allen Institute for Cell Science in 2020 after spending five years at Amgen, where she worked on assay development for multiple drug targets spanning oncology, inflammation,…